Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation
NCT ID: NCT01820702
Last Updated: 2013-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2010-11-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The subjects were quasi randomized alternatively by enrolment to undertake the different training interventions or to be in the control group during 5 days of immobilisation in 6° head down tilt position. The subjects were quasi randomized either to the one of the training programs or the non-training group depending on the arrival at the Institute of Aerospace Medicine.
The study started November 01st, 2010 and was finished May 29th, 2011. The first campaign lasted from November 01st to November 21sh, 2010, the second campaign from January 10th to January 30th, 2011 and the third campaign from May 09th to May 29th, 2011.
Each campaign comprised a 5 day adaptation-, a 5 day intervention phase in HDT bed rest, and a 5 day recovery phase (15 days in total) in-house at the Metabolic Ward of the Institute of Aerospace Medicine.
Baseline Data were collected during the adaptation phase (BDC Baseline Data Collection) when subjects could move free inside the lab. The intervention was administered during the bed rest phase where the subjects had to lie in bed in 6° head down tilt (HDT Head Down Tilt) position and were not allowed to get up. Recumbency was to be adhered to at all times including all activities (hygienic procedures, leisure activities). The bed rest phase was followed by a recovery phase (R+).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
defined training programme
Defined Training Programme
A Smith Machine with fixed rails was used to guide the heel raise and squat exercises in the vertical axis. A metronome was used to direct the subjects during the performance of the exercises. Squats and heel raises were performed against body weight plus the additional weight of the barbell (15 kg). The heel raises were performed with straight knees and without ankle dorsiflexion. The shallow squats were performed continuously for 3 minutes. The hopping and the cross-hopping exercises were performed without Smith Machine. The bilateral hops were performed at \~ 3 repetitions per second with 15-s rest insertions between each set. Cross-hopping was performed continuously for 3 minutes against \~ 1.3 repetitions per second. Except for the duration of the static squat, with progressed from 45 s at HDT1 to 70 s at HDT5, none of the exercises were progressed during the study. Including the scheduled rest pauses, the LRT sessions were completed in 24 minutes.
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Defined Training Programme
A Smith Machine with fixed rails was used to guide the heel raise and squat exercises in the vertical axis. A metronome was used to direct the subjects during the performance of the exercises. Squats and heel raises were performed against body weight plus the additional weight of the barbell (15 kg). The heel raises were performed with straight knees and without ankle dorsiflexion. The shallow squats were performed continuously for 3 minutes. The hopping and the cross-hopping exercises were performed without Smith Machine. The bilateral hops were performed at \~ 3 repetitions per second with 15-s rest insertions between each set. Cross-hopping was performed continuously for 3 minutes against \~ 1.3 repetitions per second. Except for the duration of the static squat, with progressed from 45 s at HDT1 to 70 s at HDT5, none of the exercises were progressed during the study. Including the scheduled rest pauses, the LRT sessions were completed in 24 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 65 - 85 kg
* Not a competitive athlete
* Non-smoker, for at least six months before the start of the study
* In the position to participate in the complete study
* Demonstrable social insurance and official certificate of absence of criminal record
* Successful completion of screening examination
* Provision of Declaration on Consent at the start of the study
Exclusion Criteria
* Smoking
* Vegetarian, vegan
* Migraine
* Previous psychiatric illness
* Claustrophobia
* Hiatus hernia
* Gastro-oesophageal reflux
* Diabetes mellitus
* Rheumatic illness
* Muscle or joint disorder
* Prolapse of intervertebral disk
* Pronounced orthostatic intolerance
* Hyperlipidaemia (deviations from standard values, standard values: TG \< 180 mg/dl, cumulative CH \< 200 mg/dl, HDL \> 35 mg/dl, LDL \< 160 mg/dl)
* Renal dysfunction (deviation from plasma creatinin standard values, standard value \< 1.20 mg/dl)
* Thyroid dysfunction (deviation from standard values for plasma TSH, standard value TSH 0.27 - 4.20 U/l)
* Hyperhomocysteinemia (deviation from standard value for plasma homocysteine, standard value homocysteine \>15 µmol/l)
* Hyper-, Hypouricemia (deviation from plasma uric acid standard values, age dependent standard value 3.0-6.9 mg/dl)
* Hyper-, Hypocalcemia (deviation from plasma calcium standard values, age dependent standard value 2.15-2.64 mmol/l)
* Anaemia: (\< as standard values for plasma haemoglobin, standard values for men 13.5-17.5 g/dl)
* Iron deficiency: ferritin \< 30 µg/l
* Vitamin D deficiency: D3-25-OH \< 50 ng/ml
* Blood gas values deviating from the normal values:
* pH 7.38-7.42
* pCO2 34-45 mmHg
* pO2 79-98 mmHg
* HCO3 20-28 mmol/l
* Base deviation ± 2 mmol/l
* Family history of thrombosis or positive response in thrombosis screening procedure: Biochemical analysis of the following parameter: ATIII, protein C and S activities, factor V Leiden, prothrombin mutants, lupus PTT
* Chronic back complaints
* Bone fracture in the year preceding the study
* Bone density of the femur and lower spine (L1-L4) 1.5 SD ≤ t-score
* Metal implants or other kinds of bone synthesis materials
* Participation in another clinical study within the last 2 months before start of this study
* Imprisoned at the time of the study
* Any other condition which makes the test subject unsuitable for study inclusion in the opinion of the examiner
20 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Space Agency
OTHER
University Hospital, Angers
OTHER_GOV
Politecnico di Milano
OTHER
University Hospital, Bonn
OTHER
University of Zurich
OTHER
Leiden University Medical Center
OTHER
German Sport University, Cologne
OTHER
DLR German Aerospace Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edwin Mulder, Dr.
Role: STUDY_DIRECTOR
German Aerospace Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Aerospace Center (DLR)
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Contract 22126/08/NL/VJ (SAG)
Identifier Type: -
Identifier Source: org_study_id